Publication | Closed Access

Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia

Functional HyperglycemiaAldo-keto ReductasePotent Aldose ReductaseBiochemistryMedicineDiabetesPharmacologyPharmaceutical ChemistryDiarylmethane CompoundsDrug DiscoveryGlycosylation